Literature DB >> 12143349

Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy.

A Bernasconi1, E Tasch, F Cendes, L M Li, D L Arnold.   

Abstract

Whether temporal lobe epilepsy (TLE) is the result of an isolated, early injury or whether there is ongoing neuronal damage due to seizures is often debated. We attempted to examine the long-term effect of seizures using proton magnetic resonance spectroscopic imaging (1H-MRSI), which can quantify neuronal loss or dysfunction based on reduced signals from the neuronal marker N-acetylaspartate (NAA). We performed 1H-MRSI in 82 consecutive patients with medically intractable, non-foreign-tissue TLE to determine whether there was a correlation between seizure frequency, type or duration of epilepsy and NAA to creatine ratios (NAA/Cr). Spectroscopic resonance intensities were categorized as to whether they were measured from the temporal lobe ipsilateral or contralateral to the predominant EEG focus. Ipsilateral and contralateral NAA/Cr was negatively correlated with duration of epilepsy. Furthermore, patients with frequent generalized tonic-clonic seizures had lower NAA/Cr than patients with no or rare generalized tonic-clonic seizures. The results suggest that although an early injury may cause asymmetric temporal lobe damage that is present at the onset of epilepsy, generalized seizures may induce additional neuronal damage that progresses over the course of the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12143349     DOI: 10.1016/S0079-6123(02)35027-1

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  13 in total

1.  Effect of seizure on hippocampus in mesial temporal lobe epilepsy and neocortical epilepsy: an MRS study.

Authors:  S K Lee; D W Kim; K K Kim; C K Chung; I C Song; K H Chang
Journal:  Neuroradiology       Date:  2005-09-13       Impact factor: 2.804

Review 2.  Neuroimaging of epilepsy: therapeutic implications.

Authors:  Ruben I Kuzniecky
Journal:  NeuroRx       Date:  2005-04

3.  Progressive, potassium-sensitive epileptiform activity in hippocampal area CA3 of pilocarpine-treated rats with recurrent seizures.

Authors:  Daniel P McCloskey; Helen E Scharfman
Journal:  Epilepsy Res       Date:  2011-08-30       Impact factor: 3.045

Review 4.  Utility of magnetic resonance spectroscopic imaging for human epilepsy.

Authors:  Jullie W Pan; Ruben I Kuzniecky
Journal:  Quant Imaging Med Surg       Date:  2015-04

5.  TGFβ1 treatment reduces hippocampal damage, spontaneous recurrent seizures, and learning memory deficits in pilocarpine-treated rats.

Authors:  Liang-Yong Li; Jia-Lin Li; Hui-Min Zhang; Wen-Ming Yang; Kai Wang; Yuan Fang; Yu Wang
Journal:  J Mol Neurosci       Date:  2012-08-31       Impact factor: 3.444

6.  Apoptosis, Bcl-2 family proteins and caspases: the ABCs of seizure-damage and epileptogenesis?

Authors:  Tobias Engel; David C Henshall
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2009-03-30

7.  Contralateral medial temporal lobe damage in right but not left temporal lobe epilepsy: a (1)H magnetic resonance spectroscopy study.

Authors:  F Zubler; M Seeck; T Landis; F Henry; F Lazeyras
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

8.  Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma.

Authors:  Tobias Engel; Brona M Murphy; Seiji Hatazaki; Eva M Jimenez-Mateos; Caoimhin G Concannon; Ina Woods; Jochen H M Prehn; David C Henshall
Journal:  FASEB J       Date:  2009-11-04       Impact factor: 5.191

9.  Elevated p53 and lower MDM2 expression in hippocampus from patients with intractable temporal lobe epilepsy.

Authors:  Tobias Engel; Brona M Murphy; Clara K Schindler; David C Henshall
Journal:  Epilepsy Res       Date:  2007-10-17       Impact factor: 3.045

10.  Apparent diffusion coefficient mapping of the hippocampus and the amygdala in pharmaco-resistant temporal lobe epilepsy.

Authors:  P M Gonçalves Pereira; E Oliveira; P Rosado
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.